185 results on '"Smyth, Hugh D.C."'
Search Results
2. The forgotten material: Highly dispersible and swellable gelatin-based microspheres for pulmonary drug delivery of cromolyn sodium and ipratropium bromide
3. Development of low-cost, weight-adjustable clofazimine mini-tablets for treatment of tuberculosis in pediatrics
4. Twin-screw continuous mixing: Effect of mixing elements and processing parameters on properties of aerosol powders
5. Twin-Screw Continuous Mixing Can Produce Dry Powder Inhalation Mixtures for Pulmonary Delivery
6. Development of a novel method for the continuous blending of carrier-based dry powders for inhalation using a co-rotating twin-screw extruder
7. Identification of Stability Constraints in the Particle Engineering of an Inhaled Monoclonal Antibody Dried Powder
8. Preparation of astaxanthin‐loaded composite micelles with coaxial electrospray technology for enhanced oral bioavailability and improved antioxidation capability.
9. Peptides as surface coatings of nanoparticles that penetrate human cystic fibrosis sputum and uniformly distribute in vivo following pulmonary delivery
10. Preparation of Astaxanthin‐loaded Composite Micelles via Coaxial Electrospray Technology for Enhanced Oral Bioavailability and Improved Antioxidation Capability
11. Self-assembling of graphene oxide on carbon quantum dot loaded liposomes
12. Development, Characterization, and In Vitro Testing of Co-Delivered Antimicrobial Dry Powder Formulation for the Treatment of Pseudomonas aeruginosa Biofilms
13. Pharmaco-complexity
14. A critical perspective on future developments based on the knowledge we have now
15. Fundamentals in nasal drug delivery
16. Formulation and device design to increase nose to brain drug delivery
17. Carrier-free high-dose dry powder inhaler formulation of ibuprofen: Physicochemical characterization and in vitro aerodynamic performance
18. Hollow crystalline straws of diclofenac for high-dose and carrier-free dry powder inhaler formulations
19. Delivery and therapeutic applications of gene editing technologies ZFNs, TALENs, and CRISPR/Cas9
20. Enhanced cellular uptake and gene silencing activity of siRNA molecules mediated by chitosan-derivative nanocomplexes
21. Mixing of dry powders for inhalation: A review
22. Physicochemical properties of mucus and their impact on transmucosal drug delivery
23. Nebulization of a polyelectrolyte-drug system for systemic hypertension treatment
24. Formulation Approaches to Short Interfering RNA and MicroRNA: Challenges and Implications
25. Dry powder insufflation of crystalline and amorphous voriconazole formulations produced by thin film freezing to mice
26. Biodegradable pH-responsive alginate-poly (lactic-co-glycolic acid) nano/micro hydrogel matrices for oral delivery of silymarin
27. Effects of mild processing pressures on the performance of dry powder inhaler formulations for inhalation therapy (1): Budesonide and lactose
28. Mitotropic triphenylphosphonium doxorubicin-loaded core-shell nanoparticles for cellular and mitochondrial sequential targeting of breast cancer
29. Development of PEGylated chitosan/CRISPR-Cas9 dry powders for pulmonary delivery via thin-film freeze-drying
30. Photo-induced synthesis, characterization and swelling behavior of poly(2-hydroxyethyl methacrylate) grafted carboxymethyl chitosan
31. Poly(ethylene glycol)–carboxymethyl chitosan-based pH-responsive hydrogels: photo-induced synthesis, characterization, swelling, and in vitro evaluation as potential drug carriers
32. Broad-Spectrum, Patient-Adaptable Inhaled Niclosamide-Lysozyme Particles are Efficacious Against Coronaviruses in Lethal Murine Infection Models
33. Gap Junction Liposomes for Efficient Delivery of Chemotherapeutics to Solid Tumors
34. Pharmaco-Complexity
35. In vivo efficacy of a dry powder formulation of ciprofloxacin-copper complex in a chronic lung infection model of bioluminescent Pseudomonas aeruginosa
36. Post-inhalation cough with therapeutic aerosols: Formulation considerations
37. Influence of size and surface roughness of large lactose carrier particles in dry powder inhaler formulations
38. A novel dry powder inhaler: Effect of device design on dispersion performance
39. Biodegradable nano-micro carrier systems for sustained pulmonary drug delivery: (I) Self-assembled nanoparticles encapsulated in respirable/swellable semi-IPN microspheres
40. Strategies to facilitate or block nose-to-brain drug delivery
41. Antibiofilm formulations and use thereof
42. The influence of formulation variables on the performance of alternative propellant-driven metered dose inhalers
43. Contributors
44. Inhalable microparticles loaded with a fluoroquinolone/metal cation complex for the treatment of respiratory diseases
45. M13 phage display to identify a permeating peptide against hyperconcentrated mucin
46. A human skin high-throughput formulation screening method using a model hydrophilic drug
47. Mucus-penetrating phage-displayed peptides for improved transport across a mucus-like model
48. Dosing considerations for inhaled biologics
49. PEGylated Chitosan for Nonviral Aerosol and Mucosal Delivery of the CRISPR/Cas9 System in Vitro
50. A modified USP induction port to characterize nasal spray plume geometry and predict turbinate deposition under flow
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.